vs
Side-by-side financial comparison of ENANTA PHARMACEUTICALS INC (ENTA) and GENCOR INDUSTRIES INC (GENC). Click either name above to swap in a different company.
GENCOR INDUSTRIES INC is the larger business by last-quarter revenue ($23.6M vs $18.6M, roughly 1.3× ENANTA PHARMACEUTICALS INC). GENCOR INDUSTRIES INC runs the higher net margin — 14.6% vs -64.1%, a 78.7% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs -25.0%). GENCOR INDUSTRIES INC produced more free cash flow last quarter ($10.1M vs $-11.8M). Over the past eight quarters, ENANTA PHARMACEUTICALS INC's revenue compounded faster (4.5% CAGR vs -23.9%).
Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.
Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.
ENTA vs GENC — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $18.6M | $23.6M |
| Net Profit | $-11.9M | $3.4M |
| Gross Margin | — | 28.7% |
| Operating Margin | -60.5% | 13.2% |
| Net Margin | -64.1% | 14.6% |
| Revenue YoY | 9.8% | -25.0% |
| Net Profit YoY | 46.4% | -9.8% |
| EPS (diluted) | $-0.42 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.6M | $23.6M | ||
| Q3 25 | $15.1M | $18.8M | ||
| Q2 25 | $18.3M | $27.0M | ||
| Q1 25 | $14.9M | $38.2M | ||
| Q4 24 | $17.0M | $31.4M | ||
| Q3 24 | $14.6M | $20.9M | ||
| Q2 24 | $18.0M | $25.6M | ||
| Q1 24 | $17.1M | $40.7M |
| Q4 25 | $-11.9M | $3.4M | ||
| Q3 25 | $-18.7M | $1.9M | ||
| Q2 25 | $-18.3M | $3.8M | ||
| Q1 25 | $-22.6M | $6.1M | ||
| Q4 24 | $-22.3M | $3.8M | ||
| Q3 24 | $-28.8M | $1.5M | ||
| Q2 24 | $-22.7M | $2.6M | ||
| Q1 24 | $-31.2M | $6.2M |
| Q4 25 | — | 28.7% | ||
| Q3 25 | — | 24.2% | ||
| Q2 25 | — | 26.5% | ||
| Q1 25 | — | 29.7% | ||
| Q4 24 | — | 27.6% | ||
| Q3 24 | — | 25.6% | ||
| Q2 24 | — | 23.9% | ||
| Q1 24 | — | 30.3% |
| Q4 25 | -60.5% | 13.2% | ||
| Q3 25 | -121.6% | -1.2% | ||
| Q2 25 | -103.2% | 11.6% | ||
| Q1 25 | -164.3% | 17.0% | ||
| Q4 24 | -138.8% | 14.7% | ||
| Q3 24 | -204.4% | 5.9% | ||
| Q2 24 | -134.6% | 7.8% | ||
| Q1 24 | -192.1% | 17.4% |
| Q4 25 | -64.1% | 14.6% | ||
| Q3 25 | -123.6% | 10.2% | ||
| Q2 25 | -99.7% | 14.2% | ||
| Q1 25 | -151.7% | 16.0% | ||
| Q4 24 | -131.4% | 12.1% | ||
| Q3 24 | -197.3% | 6.9% | ||
| Q2 24 | -126.1% | 10.0% | ||
| Q1 24 | -182.7% | 15.3% |
| Q4 25 | $-0.42 | $0.23 | ||
| Q3 25 | $-0.88 | $0.13 | ||
| Q2 25 | $-0.85 | $0.26 | ||
| Q1 25 | $-1.06 | $0.42 | ||
| Q4 24 | $-1.05 | $0.26 | ||
| Q3 24 | $-1.36 | $0.10 | ||
| Q2 24 | $-1.07 | $0.17 | ||
| Q1 24 | $-1.47 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | $147.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $126.6M | $215.2M |
| Total Assets | $329.5M | $228.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.4M | $147.7M | ||
| Q3 25 | $32.3M | $136.3M | ||
| Q2 25 | $44.8M | $136.0M | ||
| Q1 25 | $60.2M | $143.7M | ||
| Q4 24 | $84.3M | $130.1M | ||
| Q3 24 | $37.2M | $115.4M | ||
| Q2 24 | $35.8M | $116.6M | ||
| Q1 24 | $63.5M | $117.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $126.6M | $215.2M | ||
| Q3 25 | $64.7M | $211.8M | ||
| Q2 25 | $79.3M | $209.9M | ||
| Q1 25 | $93.5M | $206.1M | ||
| Q4 24 | $111.8M | $200.0M | ||
| Q3 24 | $128.8M | $196.1M | ||
| Q2 24 | $148.9M | $194.7M | ||
| Q1 24 | $166.1M | $192.1M |
| Q4 25 | $329.5M | $228.9M | ||
| Q3 25 | $280.7M | $222.6M | ||
| Q2 25 | $301.0M | $220.2M | ||
| Q1 25 | $323.0M | $223.9M | ||
| Q4 24 | $348.6M | $218.2M | ||
| Q3 24 | $376.7M | $208.1M | ||
| Q2 24 | $398.8M | $201.8M | ||
| Q1 24 | $413.6M | $206.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.7M | $11.1M |
| Free Cash FlowOCF − Capex | $-11.8M | $10.1M |
| FCF MarginFCF / Revenue | -63.6% | 43.0% |
| Capex IntensityCapex / Revenue | 0.8% | 4.1% |
| Cash ConversionOCF / Net Profit | — | 3.23× |
| TTM Free Cash FlowTrailing 4 quarters | $-18.5M | $-3.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.7M | $11.1M | ||
| Q3 25 | $-6.5M | $-275.0K | ||
| Q2 25 | $17.5M | $-23.9M | ||
| Q1 25 | $-13.5M | $12.4M | ||
| Q4 24 | $-16.8M | $14.8M | ||
| Q3 24 | $-10.4M | $-3.2M | ||
| Q2 24 | $-14.8M | $-1.0M | ||
| Q1 24 | $-28.6M | $11.7M |
| Q4 25 | $-11.8M | $10.1M | ||
| Q3 25 | $-7.9M | $-1.3M | ||
| Q2 25 | $17.4M | $-24.4M | ||
| Q1 25 | $-16.0M | $12.3M | ||
| Q4 24 | $-25.5M | $14.5M | ||
| Q3 24 | $-19.4M | $-3.3M | ||
| Q2 24 | $-21.3M | $-1.4M | ||
| Q1 24 | $-30.3M | $11.7M |
| Q4 25 | -63.6% | 43.0% | ||
| Q3 25 | -52.5% | -6.8% | ||
| Q2 25 | 94.7% | -90.4% | ||
| Q1 25 | -107.4% | 32.2% | ||
| Q4 24 | -150.6% | 46.1% | ||
| Q3 24 | -132.5% | -15.8% | ||
| Q2 24 | -118.6% | -5.6% | ||
| Q1 24 | -177.5% | 28.7% |
| Q4 25 | 0.8% | 4.1% | ||
| Q3 25 | 9.6% | 5.4% | ||
| Q2 25 | 0.8% | 1.8% | ||
| Q1 25 | 17.0% | 0.4% | ||
| Q4 24 | 51.6% | 1.0% | ||
| Q3 24 | 61.3% | 0.4% | ||
| Q2 24 | 36.4% | 1.5% | ||
| Q1 24 | 9.8% | 0.0% |
| Q4 25 | — | 3.23× | ||
| Q3 25 | — | -0.14× | ||
| Q2 25 | — | -6.24× | ||
| Q1 25 | — | 2.04× | ||
| Q4 24 | — | 3.88× | ||
| Q3 24 | — | -2.22× | ||
| Q2 24 | — | -0.41× | ||
| Q1 24 | — | 1.87× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
